Prometheus biosciences inc.

Major-Pharmaceuticals

RXDX


Executive/
Director

Price

  • Last Close
  • $ 199.92
    $ +0.18 0.09 %
    Jun 15, 2023
  • 52-Week High/Low
  • $0 - $0
  • YTD
  • 0%

  • Trading Volume
  • 1,860,653
  • Market Cap Full
  • $ 9.6B
  • Shares Outstanding
  • 47.8M
    May 1, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - - - -4.5% -2.4% -
Q2 - - - - - - 34.2% -25.2% 86.3% -
Q3 - - - - - - -3.5% 109% - -
Q4 - - - - - - 66.8% 86.4% - -
J F M A M J J A S O N D
2024 - - - - - - - - - - - -
2023 3.3% 7.7% -12.3% 80.7% 2.5% 0.6% - - - - - -
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%0%0%178%82%0%

Earnings

2020 2021 2022
Q1 - -1.67 -0.82
Q2 - -0.49 -0.86
Q3 - -0.7 -0.9
Q4 - -0.02 -0.91
A -24.8 -2.9 -3.5

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2021 2022 2023
Mar - 39.1 47.5
Jun 38.9 39.2 47.8
Sep 38.9 40.9 -
Dec 38.9 41.9 -

Financial Ratios

20202019
Asset Management
Inventory / Stock Turnover - -
Fixed Asset Turnover 0.6 0.1
Total Asset Turnover - -
Leverage
Debt Ratio 0.1 -
Debt – Equity Ratio -0.1 -
Interest Coverage -3.6 -1.2
Equity multiplier - -0.4